DPP4 and Insulin resistance: Moreover, we found that the injection of nondiabetic plasma-treated SVFs into the adipose tissue of diabetic mice increased IL-10 expression in the adipose tissue, decreased inflammatory cytokine expression in the liver, suppressed plasma DPP4 activity and CCL2 level, and improved insulin resistance.